In Japan, Novartis’ Ultibro and GlaxoSmithKline’s LAMA/LABA combination Anoro, are approved in COPD maintenance. Meanwhile in China older drugs such as salmeterol and formoterol are commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback